Genome editing The Berkeley and San Francisco campuses of the University of California have announced a US$12-million project focused on the CRISPR/Cas9 gene-editing technology, the powerful technique that allows targeted rewriting of genomes (see Nature http://doi.org/rz6; 2014). The Innovative Genomics Initiative will receive $10 million from the Li Ka Shing Foundation in Hong Kong, with the rest made up by the two universities. Jennifer Doudna, the Berkeley-based executive director of the initiative, says that it will focus on developing the technology for human-health applications and creating a library of research resources so that others can use the technique.